Product
GP40141
1 clinical trial
3 indications
Indication
pharmacodynamicsIndication
pharmacokineticsIndication
bioequivalenceClinical trial
Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141, Powder for Solution for Subcutaneous Administration, 250 µg (GEROPHARM LLC, Russia) and Enplate®, Powder for Solution for Subcutaneous Administration, 250 µg (Amgen Europe B.V. ., Netherlands) in Healthy Volunteers With a Single Subcutaneous InjectionStatus: Recruiting, Estimated PCD: 2024-06-30